IBEX Technologies Inc V.IBT

Healthcare Biotechnology

IBEX Technologies Inc., through its wholly owned subsidiary, IBEX Pharmaceuticals Inc., manufactures and markets enzymes for biomedical use. IBEX Pharmaceutical Inc.’s primary business is the manufacture and selling of high purity enzymes for in-vitro diagnostics and research. The Company also makes and sell osteoarthritis kits (ELISA’s) for pre-clinical research. The Company has developed a proprietary expression for the production of its enzymes in Flavobacterium heparinum. This expression system allows for producing each glycosaminoglycan (GAG) enzyme separately from other enzymes therefore achieving the highest purity using a well-defined proprietary purification scheme. The Company operates in one industry segment: the production and sale of diagnostic products.

TSXV:IBT - Post by User

IBEX Technologies Inc > Ibex Peer Group Comparison

<< Previous

Bullboard Posts

Next >>

Comment by nozzpackon Jan 11, 2022 7:10pm

140 Views

Post# 34306067

RE:Ibex Peer Group Comparison

Thank you.
Once again, we see how brutally undervalued Ibex really is.

With a strong outlook for continued growth in sales and earnings and their options just set at $0.49,
It's like shooting dead fish in a barrel..

<< Previous

Bullboard Posts

Next >>

Revolutionizing medical imaging with nanocarbon-based contrast drugs